Stefan Hettwer;Stefan Kucsera;Jan Willem Vrijbloed
发明人:
Stefan Hettwer,Stefan Kucsera,Jan Willem Vrijbloed
申请号：
US13393662
公开号：
US20120208765A1
申请日:
2010.09.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Modified agrin fragment having in vivo activity, comprising at least the domains LG2 and LG3 of human agrin in covalently interlinked form and modified in such a way that the fragment cannot be cleaved by neurotrypsin for use as medicament.
